Toxic Syrup Tragedy: Child Deaths Hit 9 in MP, Rajasthan

A multi-state public health crisis has deepened in India, with the tragic death toll of children from acute kidney failure reaching nine across Madhya Pradesh and Rajasthan, all allegedly linked to the consumption of a common cough syrup. The majority of the fatalities have occurred in Madhya Pradesh’s Chhindwara district, where initial reports confirmed six child deaths, a number which local legislators and some media reports suggest has now risen, escalating the total regional count.

The crisis began to unfold in Chhindwara’s Parasia area, where between early September and late September, children—mostly under the age of seven—succumbed to severe kidney complications. Families report that the children, initially suffering from routine cold, cough, and mild fever, took over-the-counter or government-supplied cough syrups before their condition rapidly deteriorated, marked by a sudden, alarming decline in urine output (anuria) and subsequent kidney failure.

Focus on Contamination

Two specific cough syrups, identified as Coldrif and Nextro-DS, have been found to have been administered to most of the deceased children, immediately placing them under an intense scanner. Authorities in Chhindwara have swiftly banned the sale and prescription of these two syrups and have issued a strict advisory to medical practitioners to only prescribe symptom-specific medicines.

The central focus of the investigation is the potential presence of Diethylene Glycol (DEG)—a highly toxic chemical—in the syrups, which is known to cause severe kidney damage. Unconfirmed preliminary findings from a kidney biopsy of one of the deceased children reportedly suggested DEG contamination. The suspicion has brought back grim memories of past pharmaceutical poisoning tragedies linked to DEG contamination in Indian-made syrups, both domestically and internationally.

Multi-Agency Investigation Underway

In response to the mounting crisis, both central and state government agencies have launched a comprehensive, multi-pronged investigation. Teams from the National Centre for Disease Control (NCDC) and the Indian Council of Medical Research (ICMR) have been deployed to the affected regions in Chhindwara and Rajasthan.

These expert teams have collected a wide array of samples, including the suspected drug batches, as well as water and entomological (insect-related) samples, to definitively rule out both infectious disease outbreaks and chemical poisoning. The collected samples of the drug have been dispatched to State Drug Testing Laboratories and national institutions like the National Institute of Virology (NIV) in Pune for detailed analysis. The entire distribution chain of the implicated syrup, manufactured by a firm in Jaipur and supplied under the Chief Minister’s Free Medicine Scheme in Rajasthan, has been suspended.

While health officials await the conclusive laboratory results, the situation has ignited a fierce political debate, with the state’s Deputy Chief Minister and Health Minister initially denying any certain link between the cough syrup and the fatalities, drawing criticism from the opposition.

The tragic sequence of events has underscored critical vulnerabilities in the country’s drug regulatory and public health systems. Authorities have warned the public against self-medication and urged parents to exercise extreme caution, only administering medicine to children under the strict guidance and prescription of a registered doctor. The entire region remains on high alert as the administration works to trace and treat any further affected children and prevent this tragedy from escalating further.